About 13 results
Open links in new tab
  1. An agency of the European Union European Medicines Agency, 2025. Reproduction is authorised provided the source is acknowledged. ... NEBILET 5 mg tablets not available MA204/00201 …

  2. List of nationally authorised medicinal products Active substance(s): hydrochlorothiazide / nebivolol

  3. PSUSA/00002129/202403 - periodic safety update report single …

    Jan 23, 2025 · Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances …

  4. In view of available data on risk of hypoglycaemia with concomitant use with sulfonylureas from the literature, in view of a plausible mechanism of action, and in line with the PRAC decision …

  5. On 17 July 2015, the Paediatric Committee of the European Medicines Agency agreed a product-specific waiver* for hydrochlorothiazide / nebivolol (hydrochloride) for treatment of …

  6. EMEA-001761-PIP01-15 - paediatric investigation plan

    P/0200/2015: EMA decision of 4 September 2015 on the granting of a product-specific waiver for hydrochlorothiazide / nebivolol (hydrochloride) (EMEA-001761-PIP01-15)

  7. European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged.

  8. Homepage | European Medicines Agency

    Homepage | European Medicines Agency

  9. OR ‘MICARDIS HCT’ OR ‘MICARDIS PLUS’ OR ‘MICARDISPLUS’ OR ‘MICOMBI’ OR ‘MICOMBI AP’ OR ‘MICOMBI COMBINATION TABLETS AP’ OR ‘MICROZIDE’ OR ‘MILORIDE’ OR …

  10. Rasilez HCT 150 mg/12,5 mg Filmtabletten Jede Filmtablette enthält 150 mg Aliskiren (als Hemifumarat) und 12,5 mg Hydrochlorothiazid.